Chinese herbal medicine maker Shijiazhuang Yiling Pharmaceutical will raise up to 2.25 billion yuan ($348 million) in an initial public offering (IPO) in Shenzhen, a third more than originally planned.
Chinese herbal medicine maker Shijiazhuang Yiling Pharmaceutical will raise up to 2.25 billion yuan ($348 million) in an initial public offering (IPO) in Shenzhen, a third more than originally planned.
The private equity unit of Citic Securities Co, China's biggest listed brokerage is making its foray into debt financing by launching a 5 billion yuan ($773 million) mezzanine fund, an investor said.
Stocks on the Chinese mainland fell for the first time in four days on concern the nation's inflation rate will jump this month and the European debt crisis will curb demand for commodities and slow economic growth.
Accounting and ownership issues could shut some 35 Chinese companies' doors to capital markets.
More cities experienced cooling property prices in June, compared to May, as policies targeting speculation kicked in.
Chinese shares fell on Monday as property developers dropped on speculation that the government may take further steps to cool its scorching real estate market.
Hong Kong stocks lost 70.63 points, or 0.32 percent, to close at 21,804.75 on Monday.
China's stock index futures closed mixed on Monday with the contract for July, the most actively traded, down 0.38percent from the previous day to 3,122.8 points.
The ChiNext Index, launched by the Shenzhen Stock Exchange (SZSE) on June 1, 2010, fell 5.02 points, or 0.53 percent, to 946.12 on Monday.
Chinese shares closed lower Monday with the benchmark Shanghai Composite Index down 0.12 percent, or 3.48 points, to close at 2,816.69.
Middle-class families play significant roles in China nowadays, and they tend to manage their growing wealth more rationally in the face of a rising consumer price index (CPI).